Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · IEX Real-Time Price · USD
12.24
-0.65 (-5.04%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Third Harmonic Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022
Market Capitalization
501443174
Market Cap Growth
131.34%153.97%-
Enterprise Value
242177-111
PE Ratio
--14.36-4.96
PB Ratio
1.901.650.60
P/FCF Ratio
-19.02-21.50-4.99
P/OCF Ratio
-19.18-21.68-4.99
EV/EBITDA Ratio
-4.32-5.863.15
EV/EBIT Ratio
-4.22-5.753.15
EV/FCF Ratio
-6.18-8.603.17
Debt / Equity Ratio
0.010.010.02
Debt / EBITDA Ratio
-0.13-0.13-0.12
Debt / FCF Ratio
-0.19-0.19-0.12
Quick Ratio
65.5249.7551.18
Current Ratio
66.1050.2951.80
Return on Equity (ROE)
-10.90%-11.20%-29.00%
Return on Assets (ROA)
-10.60%-10.80%-16.40%
Return on Capital (ROIC)
-16.18%-16.10%-12.85%
Earnings Yield
-5.90%-6.96%-20.16%
FCF Yield
-4.03%-4.65%-20.05%
Buyback Yield / Dilution
-1.96%-176.21%-254.97%
Total Shareholder Return
-1.96%-176.21%-254.97%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).